Hard Lessons: GSK China GM Opens Up On Commercial Model Shift
This article was originally published in PharmAsia News
How is GSK’s drastic commercial model change progressing in China? What lessons are there for other multinational drug firms grappling with a rapidly changing emerging market? The company’s top local executive shares his views for the first time in nearly two years.